Exp Clin Endocrinol Diabetes 2008; 116: S46-S49
DOI: 10.1055/s-2008-1081486
Article

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Reduced Insulin Secretion and Content in VEGF-A Deficient Mouse Pancreatic Islets

N. Jabs 1 , I. Franklin 2 , M. B. Brenner 3 , J. Gromada 4 , N. Ferrara 5 , C. B. Wollheim 2 , E. Lammert 1
  • 1Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
  • 2Department of Cell Physiology & Metabolism, University Medical Center, Geneva 4, Switzerland
  • 3Lilly Research Laboratories, Hamburg, Germany
  • 4Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, MA, USA
  • 5Genentech, 1 DNA Way, South San Francisco, California, USA
Further Information

Publication History

received 18.02.2008

accepted 20.03.2008

Publication Date:
05 September 2008 (online)

Abstract

Mice, deficient for vascular endothelial growth factor VEGF-A in pancreatic islets, have reduced insulin gene expression levels and an impaired glucose tolerance. Here, we investigated whether VEGF-A was required for physiological glucose-stimulated insulin secretion and insulin content. We performed in situ pancreas perfusions and islet perifusions on mice lacking VEGF-A in the pancreatic epithelium in order to study their ability to secrete insulin in response to glucose. We identified insulin secretion defects in the pancreata of VEGF-A deficient mice, including a delayed and blunted response to glucose. Islet perifusion experiments revealed a missing first phase and weaker second phase of insulin secretion, in two of three VEGF-A deficient mice. On average, insulin content in VEGF-A deficient islets was significantly reduced when compared with control islets. We conclude that VEGF-A is required in pancreatic islets for normal glucose-stimulated insulin secretion and physiological insulin content. Thus, VEGF-A is a key factor for pancreatic islet function.

References

  • 1 Kamba T, Tam BY, Hashizume H. et al . VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature.  Am J Physiol Heart Circ Physiol. 2006;  290 H560-H576
  • 2 Inoue M, Hager JH, Ferrara N, Gerber HP, Hanahan D. VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis.  Cancer Cell. 2002;  1 193-202
  • 3 Lammert E, Gu G, MacLaughlin M. et al . Role of VEGF-A in vascularization of pancreatic islets.  Curr Biol. 2003;  13 1070-1074
  • 4 Zhang N, Richter A, Suriawinata J. et al . Elevated vascular endothelial growth factor production in islets improves islet graft vascularization.  Diabetes. 2004;  53 963-970
  • 5 Lai Y, Schneider D, Kidszun A. et al . Vascular endothelial growth factor increases functional beta-cell mass by improvement of angiogenesis of isolated human and murine pancreatic islets.  Transplantation. 2005;  79 1530-1536
  • 6 Gorogawa S, Fujitani Y, Kaneto H. et al . Insulin secretory defects and impaired islet architecture in pancreatic beta-cell-specific STAT3 knockout mice.  Biochem Biophys Res Commun. 2004;  319 1159-1170
  • 7 Nikolova G, Jabs N, Konstantinova I. et al . The vascular basement membrane: a niche for insulin gene expression and beta cell proliferation.  Dev Cell. 2006;  10 397-405
  • 8 Knoch KP, Bergert H, Borgonovo B. et al . Polypyrimidine tract-binding protein promotes insulin secretory granule biogenesis.  Nat Cell Biol. 2004;  6 207-214
  • 9 Maechler P, Gjinovci A, Wollheim CB. Implication of glutamate in the kinetics of insulin secretion in rat and mouse perfused pancreas.  Diabetes. 2002;  51 ((Suppl 1)) S99-S102
  • 10 Brenner MB, Mest HJ. A buffer temperature controlled perifusion system to study temperature dependence and kinetics of insulin secretion in MIN6 pseudoislets.  J Pharmacol Toxicol Methods. 2004;  50 53-57

Correspondence

E. Lammert

Max Planck Institute of Molecular Cell Biology and Genetics

Pfotenhauerstr. 108

01307 Dresden

Germany

Phone: +49/351/210 27 77

Fax: +49/351/210 12 09

Email: lammert@mpi-cbg.de

    >